- Patent Title: Peptide effective in control of geminivirus disease and use thereof
-
Application No.: US16318990Application Date: 2017-07-20
-
Publication No.: US11427833B2Publication Date: 2022-08-30
- Inventor: Yasunori Machida , Norifusa Matsuo , Masato Omatsu , Takanori Suzuki , Mika Tanaka
- Applicant: ISHIHARA SANGYO KAISHA, LTD.
- Applicant Address: JP Osaka
- Assignee: ISHIHARA SANGYO KAISHA, LTD.
- Current Assignee: ISHIHARA SANGYO KAISHA, LTD.
- Current Assignee Address: JP Osaka
- Agency: Greenblum & Bernstein, P.L.C.
- Priority: JPJP2016-143695 20160721
- International Application: PCT/JP2017/026196 WO 20170720
- International Announcement: WO2018/016556 WO 20180125
- Main IPC: C12N15/82
- IPC: C12N15/82 ; A01H6/82 ; A01H6/60 ; A01H6/20 ; A01H6/54 ; C07K14/415 ; C12N7/00 ; C12N15/09

Abstract:
Disclosed are a decoy peptide which is a partial peptide of ASYMMETRIC LEAVES1 (AS1), the decoy peptide being capable of interacting with βC1 encoded by a betasatellite of a virus belonging to the family Geminiviridae, a nucleic acid encoding the decoy peptide, an expression vector comprising the nucleic acid, a geminivirus disease control agent comprising the decoy peptide or the nucleic acid, a method for controlling a geminivirus disease using the geminivirus disease control agent, a transgenic plant into which the nucleic acid is introduced, and a method for reducing a disease symptom caused by a virus that comprises βC1 and belongs to the family Geminiviridae, using the nucleic acid. Also disclosed is a method for evaluating the degree of reduction in a disease symptom caused by a virus that comprises βC1 and belongs to the family Geminiviridae.
Public/Granted literature
- US20190300584A1 PEPTIDE EFFECTIVE IN CONTROL OF GEMINIVIRUS DISEASE AND USE THEREOF Public/Granted day:2019-10-03
Information query
IPC分类: